Funded Tech Companies
Sen-Jam Pharmaceutical
Looking for the VC firms that backed Sen-Jam Pharmaceutical? 5 Horizons Capital invested in this biopharmaceutical company.
Company Overview
Company Name
Sen-Jam Pharmaceutical
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling inflammation-based diseases such as viral respiratory infections from coronaviruses such as COVID-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, opioid withdrawal and even the infamous hangover. Using our patented proprietary technology of "next generation anti-inflammatories" and the accelerated 505(b)2 pathway, we're addressing the root causes of autoimmune inflammation--much like how Ozempic targets metabolic inflammation.. Our mission: to transform how we treat inflammation and reshape the business of pain relief for the betterment of humanity.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/22/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Iversen
Company Investors
Browse more funded tech companies:
Semtek Innovative Solutions | Sena Health
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs